SlideShare a Scribd company logo
1 of 26
THE MANAGEMENT OF
WOMEN WITH MINOR
SMEAR ABNORMALITIES
Dr Grainne Flannelly
Colposcopy Course on line
BSCCP
Objectives
• If you have a low grade smear what are the chances of
having High grade CIN?
• What are we trying to achieve in managing these women?
• Management strategies – example of policies in evolution
• How should these women be managed at Colposcopy?
BSCCP on line course 2
Aim of cervical screening –public health
perspective
Reduce the
incidence and
mortality of cervical
cancer
Detection and
treatment of high
grade precancerous
lesions
BSCCP on line course 3
Aim of Cervical screening - woman's
perspective
To achieve a normal
smear result!!!
In the presence of any
uncertainty to get
further information
BSCCP on line course 4
Low grade cytological abnormalities in the
NHSCSP
In England in
2009, 239,907
women got a smear
result with minor
abnormality
Most of these
women do not have
high grade CIN
Category Number
Inadequate 105,258
Negative 3,215,943
Borderline 153,471
Mild dyskaryosis 86,436
Moderate Dyskaryosis
21,839
Severe Dyskaryosis
24,186
?Invasive cancer 929
Glandular 1,882
Total 3,609,944
(NHS statistics 2009/2010)
BSCCP on line course 5
In England in 2009, 51% of referrals to colposcopy were for
low grade abnormalities
Inadequate
2%
BNA
19%
Mild
32%
Moderate
13%
Severe
15%
Glandular
0%
Clinical
urgent
1% Clinical non
urgent
14%
Other
4%
Referrals to colposcopy
BSCCP on line course 6
Management Of Low Grade Smears; In Search Of
Balance
Risk of
Cancer
Risk of
Harm
BSCCP on line course 7
Management options; the tools
Repeat
smears in the
community
Colposcopy
and biopsy
Triage with
HPV tests?
Traditional management
• Cytological surveillance with
colposcopy for repeated low
grade.
Recent guidelines
• Immediate colposcopy is
ideal for mild dyskaryosis”
News: April 2011
• Introduction of HPV Triage
for low grade abnormalities
BSCCP on line course 8
Core Issues
Delay in
diagnosis of
high grade
CIN
Default
Psychological
impact
Cost
BSCCP on line course 9
Advantages of early colposcopy strategy
Recognition of covert CIN II-III
Treatment/Eradication of abnormal cells
Return to normal cytology
Reassurance for woman
Reassurance for doctor
BSCCP on line course 10
Low grade abnormalities and the
natural history of HPV infection
•Transmission by
sex
•Lifetime risk 80% -
most within 18
months
Exposure
•Transient
•Most resolve
within 18 months
Infection
•Less than 20%
persist
•No antibodies
detectable
Persistence
•Virus integrates
into host DNA
Malignant
Transformation •Loss of tumour
supressor gene
E2
•Uncontrolled cells
division
CIN
BSCCP on line course 11
Natural history;ASCUS /Borderline smears are
associated with an increased risk of high grade
CIN
• Risk of High grade CIN 10.1%,
• Risk of invasive cancer 0.62%,
• Relative risk of 15-30 for high grade
CIN/Cancer
ASCUS:
• Relative risk of 3.5 for high grade
CIN/Cancer
ASCUS index
smear followed by
a normal smear
Nygard,J.F., Acta Cytol, 2003.
BSCCP on line course 12
Natural history: Mild dyskaryosis - risk of
subsequent high grade disease?
Risk of Subsequent
High Grade
• Nassiel (n=555) 26%
• Fletcher (n=666) 14%
• Robertson (n=1347) 19%
Risk of cancer on
surveillance
• 0.5% (Robertson)
• 1% (Kirby)
BSCCP on line course 13
Woman's attitudes to mildly abnormal smear
result
47% of women
in immediate
colposcopy
group thought
they had cancer
33% of women
in the
surveillance
group thought
they had cancer
Following an
educational
interview
• Most women
with LSil chose
Colposcopy
Following an
educational
interview
• Most women with
ASCUS chose
virus testing
(ALTS Study)
BSCCP on line course 14
What about including patient choice?
476 women randomised to either
surveillance or choice between
immediate colposcopy or
surveillance
Both groups of
women showed
high levels of
anxiety initially.
No difference
between the two
groups
Fewer women
defaulted in the
choice arm
(Kitchener, 2004)
BSCCP on line course 15
Cytological Surveillance is less efficient
than immediate colposcopy - Tombola
Detection of high grade
disease
• Immediate colposcopy
Cumulative detection -
79/1000 person years
• Cytological surveillance
Cumulative detection
58/1000 person years.
Anxiety
• Both strategies were
associated with anxiety
• No difference between two
arms
(BMJ, 2009)
BSCCP on line course 16
Time for a radical change in approach?
BSCCP on line course 17
HPVAs Triage For Women WithASCUS;AMeta-
analysis
• Sensitivity 94.8%
• Specificity 67.3%
HPV testing
(HC 2)
• Sensitivity 81.8%
• Specificity 57.6%
Cytology
The addition of HPV testing to cytology increased sensitivity
Arbyn et al, J Natl Cancer Inst. 2004 Feb 18;96(4):280-93.
BSCCP on line course 18
HPV testing increases the numbers referred
for colposcopy
3488 women with
ASCUS/LSIL
HPV Testing
• 95.9% sensitivity for high
grade CIN
Would have resulted in
56% of women being
referred for colposcopy
(ALTS study, Solomons, 2001)
Size of impact depends on preexisting policy regarding women with
mild dyskaryosis
BSCCP on line course 19
NHS Triage Pilot in Three laboratories BMJ 2006
• Repeat smears reduced significantly (70-87%)
• Referrals to colposcopy doubled
BSCCP on line course 20
Risks of Triage; Psychosocial
HPV triage has the
potential to
increase anxiety in
women
• It could result in
an explicit
diagnosis of a
sexually
transmitted
infection
• Increased rate of
Solutions
• High quality
information
• Adequate
colposcopy
capacity to
maintain low
waiting times
BSCCP on line course 21
Psychological Impact; Australia
• HPV positive result
was associated
with initial distress
as was repeat pap
testing
• Levels of distress
decreased with
time
Mc Caffrey K, BMJ 2010
BSCCP on line course 22
Women with low grade abnormalities; management
at colposcopy- Tombola
Comparison of immediate
LLETZ versus biopsy and
deferred treatment
• 60% of LLETZ showed
no CIN
• No difference in
cumulative detection of
CIN 2/3
Targeted punch
biopsies with
• Subsequent
treatment for
CIN2/3
• Cytological
surveillance for
grade I or less
Immediate
treatment with
LLETZ should be
avoided
BMJ 2009;339:b2548
BSCCP on line course 23
Management at Colposcopy
NewAlgorithm - NHSCSP Triage
Borderline/Mild dyskaryosis
HPV +
Colposcopy+-
Biopsy
Abnormal
CIN2/3
Treatment
CIN1
Repeat smear
in 12 months
Normal
HPV -
Routine
Recall
BSCCP on line course 24
Evidence for early discharge if colposcopy
normal
965 women in NHS Pilot sites with low grade cytology and HPV
+ with negative colposcopy with or without biopsy at recruitment
• 94.6% of cases of CIN2/3 were detected at the first visit to colposcopy
• 42 cases of CIN 2/3 were identified within 3 years
Kelly et al, BJOG May 2011)
Good quality colposcopy will be essential if these results are to be
reproducible in routine practice !
BSCCP on line course 25
Conclusions
The road ahead Key questions
• Role of colposcopy –
especially negative
colposcopy
• Compliance
• New tests – biomarkers?
BSCCP on line course 26

More Related Content

What's hot

Dr nisreen anfnan cervical cancer in saudi arabia last version
Dr nisreen anfnan cervical cancer in saudi arabia last versionDr nisreen anfnan cervical cancer in saudi arabia last version
Dr nisreen anfnan cervical cancer in saudi arabia last versionTariq Mohammed
 
1 prof james bently cervical cancer screening 2014
1  prof james bently cervical cancer screening 20141  prof james bently cervical cancer screening 2014
1 prof james bently cervical cancer screening 2014Tariq Mohammed
 
Colposcopy nstrumentation and principles on how to do 22
Colposcopy nstrumentation and principles on how to do 22Colposcopy nstrumentation and principles on how to do 22
Colposcopy nstrumentation and principles on how to do 22Tariq Mohammed
 
The Accuracy of Diagnostic Colposcopy using IFCPC 2011 Terminology
The Accuracy of Diagnostic Colposcopy using IFCPC 2011 TerminologyThe Accuracy of Diagnostic Colposcopy using IFCPC 2011 Terminology
The Accuracy of Diagnostic Colposcopy using IFCPC 2011 TerminologySujoy Dasgupta
 
Screening for cervical cancer
Screening for  cervical cancerScreening for  cervical cancer
Screening for cervical cancerAboubakr Elnashar
 
Cancer cervix screening
Cancer cervix screeningCancer cervix screening
Cancer cervix screeningAmir Mahmoud
 
Nulife module 6 screening for malignancies edited
Nulife module 6 screening for malignancies editedNulife module 6 screening for malignancies edited
Nulife module 6 screening for malignancies editedManinder Ahuja
 
Taking A Pap Smear
Taking A Pap SmearTaking A Pap Smear
Taking A Pap Smeardrsubir
 
Management of abnormal pap test
Management of abnormal pap testManagement of abnormal pap test
Management of abnormal pap testTariq Mohammed
 
Cervical pap smear presentation
Cervical pap smear presentationCervical pap smear presentation
Cervical pap smear presentationDonald Angstetra
 
Basics To Ca Cx Screening (Eastern Biotech)
Basics To Ca Cx Screening (Eastern Biotech)Basics To Ca Cx Screening (Eastern Biotech)
Basics To Ca Cx Screening (Eastern Biotech)Pankaj Sohaney
 
Cervical cancer screening module 1
Cervical cancer screening module 1Cervical cancer screening module 1
Cervical cancer screening module 1MMSCME
 
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist Lifecare Centre
 
Asccp management guidelines august 2014 ppt. Dr. Sharda Jain /Dr Jyoti Agarw...
Asccp management guidelines august 2014 ppt.  Dr. Sharda Jain /Dr Jyoti Agarw...Asccp management guidelines august 2014 ppt.  Dr. Sharda Jain /Dr Jyoti Agarw...
Asccp management guidelines august 2014 ppt. Dr. Sharda Jain /Dr Jyoti Agarw...Lifecare Centre
 
Cervical Screening State of the Art 2016
Cervical Screening State of the Art 2016Cervical Screening State of the Art 2016
Cervical Screening State of the Art 2016Dr Dirk Grothuesmann
 
Cervical cancer screening module 3
Cervical cancer screening module 3Cervical cancer screening module 3
Cervical cancer screening module 3MMSCME
 
HPV SCREENING & CO TESTING
HPV SCREENING & CO TESTINGHPV SCREENING & CO TESTING
HPV SCREENING & CO TESTINGNiranjan Chavan
 

What's hot (20)

Dr nisreen anfnan cervical cancer in saudi arabia last version
Dr nisreen anfnan cervical cancer in saudi arabia last versionDr nisreen anfnan cervical cancer in saudi arabia last version
Dr nisreen anfnan cervical cancer in saudi arabia last version
 
1 dr mario sideri
1  dr mario sideri 1  dr mario sideri
1 dr mario sideri
 
1 prof james bently cervical cancer screening 2014
1  prof james bently cervical cancer screening 20141  prof james bently cervical cancer screening 2014
1 prof james bently cervical cancer screening 2014
 
Colposcopy nstrumentation and principles on how to do 22
Colposcopy nstrumentation and principles on how to do 22Colposcopy nstrumentation and principles on how to do 22
Colposcopy nstrumentation and principles on how to do 22
 
The Accuracy of Diagnostic Colposcopy using IFCPC 2011 Terminology
The Accuracy of Diagnostic Colposcopy using IFCPC 2011 TerminologyThe Accuracy of Diagnostic Colposcopy using IFCPC 2011 Terminology
The Accuracy of Diagnostic Colposcopy using IFCPC 2011 Terminology
 
Screening for cervical cancer
Screening for  cervical cancerScreening for  cervical cancer
Screening for cervical cancer
 
Cancer cervix screening
Cancer cervix screeningCancer cervix screening
Cancer cervix screening
 
Nulife module 6 screening for malignancies edited
Nulife module 6 screening for malignancies editedNulife module 6 screening for malignancies edited
Nulife module 6 screening for malignancies edited
 
Taking A Pap Smear
Taking A Pap SmearTaking A Pap Smear
Taking A Pap Smear
 
Management of abnormal pap test
Management of abnormal pap testManagement of abnormal pap test
Management of abnormal pap test
 
4 dr mario sideri m k
4  dr mario sideri  m k4  dr mario sideri  m k
4 dr mario sideri m k
 
Cervical pap smear presentation
Cervical pap smear presentationCervical pap smear presentation
Cervical pap smear presentation
 
Basics To Ca Cx Screening (Eastern Biotech)
Basics To Ca Cx Screening (Eastern Biotech)Basics To Ca Cx Screening (Eastern Biotech)
Basics To Ca Cx Screening (Eastern Biotech)
 
Cervical cancer screening module 1
Cervical cancer screening module 1Cervical cancer screening module 1
Cervical cancer screening module 1
 
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
 
Asccp management guidelines august 2014 ppt. Dr. Sharda Jain /Dr Jyoti Agarw...
Asccp management guidelines august 2014 ppt.  Dr. Sharda Jain /Dr Jyoti Agarw...Asccp management guidelines august 2014 ppt.  Dr. Sharda Jain /Dr Jyoti Agarw...
Asccp management guidelines august 2014 ppt. Dr. Sharda Jain /Dr Jyoti Agarw...
 
Cervical Screening State of the Art 2016
Cervical Screening State of the Art 2016Cervical Screening State of the Art 2016
Cervical Screening State of the Art 2016
 
Cervical cancer screening module 3
Cervical cancer screening module 3Cervical cancer screening module 3
Cervical cancer screening module 3
 
HPV and Cervical Cancer Screening
HPV and Cervical Cancer ScreeningHPV and Cervical Cancer Screening
HPV and Cervical Cancer Screening
 
HPV SCREENING & CO TESTING
HPV SCREENING & CO TESTINGHPV SCREENING & CO TESTING
HPV SCREENING & CO TESTING
 

Viewers also liked

How to treat bsccp talk back to grainne
How to treat bsccp talk back to grainneHow to treat bsccp talk back to grainne
How to treat bsccp talk back to grainneDebbie Lewis
 
Lesson 7 Single Gene Disorders (H)
Lesson 7   Single Gene Disorders (H)Lesson 7   Single Gene Disorders (H)
Lesson 7 Single Gene Disorders (H)scuffruff
 
Colposcopy case studies2
Colposcopy case studies2Colposcopy case studies2
Colposcopy case studies2Tariq Mohammed
 
Genetic disorders 3
Genetic disorders 3Genetic disorders 3
Genetic disorders 3Shahab Riaz
 
Colposcopy
ColposcopyColposcopy
Colposcopydrsubir
 
Minor disorders of newborn
Minor disorders of newbornMinor disorders of newborn
Minor disorders of newbornPriya Dharshini
 

Viewers also liked (6)

How to treat bsccp talk back to grainne
How to treat bsccp talk back to grainneHow to treat bsccp talk back to grainne
How to treat bsccp talk back to grainne
 
Lesson 7 Single Gene Disorders (H)
Lesson 7   Single Gene Disorders (H)Lesson 7   Single Gene Disorders (H)
Lesson 7 Single Gene Disorders (H)
 
Colposcopy case studies2
Colposcopy case studies2Colposcopy case studies2
Colposcopy case studies2
 
Genetic disorders 3
Genetic disorders 3Genetic disorders 3
Genetic disorders 3
 
Colposcopy
ColposcopyColposcopy
Colposcopy
 
Minor disorders of newborn
Minor disorders of newbornMinor disorders of newborn
Minor disorders of newborn
 

Similar to Minor abnormalities

Cervcal cancer prevention in sa
Cervcal cancer prevention in saCervcal cancer prevention in sa
Cervcal cancer prevention in saTariq Mohammed
 
1 prof james bently cervical cancer screening 2014
1  prof james bently cervical cancer screening 20141  prof james bently cervical cancer screening 2014
1 prof james bently cervical cancer screening 2014Tariq Mohammed
 
CIN and Cervical Screening
CIN and Cervical ScreeningCIN and Cervical Screening
CIN and Cervical ScreeningPro Faather
 
Breast cancer screening
Breast cancer screeningBreast cancer screening
Breast cancer screeningBIJAPUROBG
 
2013-cervical-cancer-guideline-presentation-en.pptx
2013-cervical-cancer-guideline-presentation-en.pptx2013-cervical-cancer-guideline-presentation-en.pptx
2013-cervical-cancer-guideline-presentation-en.pptxssuser45ba6e
 
РREMALIGNANT AND MALIGNANT DISORDERS OF THE CERVIX.pdf
РREMALIGNANT AND MALIGNANT DISORDERS OF THE CERVIX.pdfРREMALIGNANT AND MALIGNANT DISORDERS OF THE CERVIX.pdf
РREMALIGNANT AND MALIGNANT DISORDERS OF THE CERVIX.pdfSyazwaniPiti
 
Report Back from SGO: What’s the Latest in Uterine Cancer?
Report Back from SGO: What’s the Latest in Uterine Cancer?Report Back from SGO: What’s the Latest in Uterine Cancer?
Report Back from SGO: What’s the Latest in Uterine Cancer?bkling
 
201405724 american-cancer-society
201405724 american-cancer-society201405724 american-cancer-society
201405724 american-cancer-societyhomeworkping4
 
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comCervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comjinekolojivegebelik.com
 
Prevention of cancer in women
Prevention of cancer in women Prevention of cancer in women
Prevention of cancer in women vandana bansal
 
Gynecologic Cancer Screening
Gynecologic Cancer Screening Gynecologic Cancer Screening
Gynecologic Cancer Screening Niranjan Chavan
 
Breast cancer screening-2021 chan hio tong
Breast cancer screening-2021 chan hio tongBreast cancer screening-2021 chan hio tong
Breast cancer screening-2021 chan hio tongjim kuok
 
ENDOMETRIAL CANCER (1).pptx
ENDOMETRIAL CANCER (1).pptxENDOMETRIAL CANCER (1).pptx
ENDOMETRIAL CANCER (1).pptxBhavesh SOBHANI
 

Similar to Minor abnormalities (20)

Cervcal cancer prevention in sa
Cervcal cancer prevention in saCervcal cancer prevention in sa
Cervcal cancer prevention in sa
 
Cervical ca prevention
Cervical ca preventionCervical ca prevention
Cervical ca prevention
 
1 prof james bently cervical cancer screening 2014
1  prof james bently cervical cancer screening 20141  prof james bently cervical cancer screening 2014
1 prof james bently cervical cancer screening 2014
 
CIN and Cervical Screening
CIN and Cervical ScreeningCIN and Cervical Screening
CIN and Cervical Screening
 
Breast cancer screening
Breast cancer screeningBreast cancer screening
Breast cancer screening
 
2013-cervical-cancer-guideline-presentation-en.pptx
2013-cervical-cancer-guideline-presentation-en.pptx2013-cervical-cancer-guideline-presentation-en.pptx
2013-cervical-cancer-guideline-presentation-en.pptx
 
Breast screening pallavi
Breast screening pallaviBreast screening pallavi
Breast screening pallavi
 
РREMALIGNANT AND MALIGNANT DISORDERS OF THE CERVIX.pdf
РREMALIGNANT AND MALIGNANT DISORDERS OF THE CERVIX.pdfРREMALIGNANT AND MALIGNANT DISORDERS OF THE CERVIX.pdf
РREMALIGNANT AND MALIGNANT DISORDERS OF THE CERVIX.pdf
 
Report Back from SGO: What’s the Latest in Uterine Cancer?
Report Back from SGO: What’s the Latest in Uterine Cancer?Report Back from SGO: What’s the Latest in Uterine Cancer?
Report Back from SGO: What’s the Latest in Uterine Cancer?
 
201405724 american-cancer-society
201405724 american-cancer-society201405724 american-cancer-society
201405724 american-cancer-society
 
Ca cervix
Ca cervixCa cervix
Ca cervix
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comCervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
 
Asccp 2013 somsak
Asccp 2013 somsakAsccp 2013 somsak
Asccp 2013 somsak
 
Prevention of cancer in women
Prevention of cancer in women Prevention of cancer in women
Prevention of cancer in women
 
Gynecologic Cancer Screening
Gynecologic Cancer Screening Gynecologic Cancer Screening
Gynecologic Cancer Screening
 
Familial gynacological malignancy
Familial gynacological malignancyFamilial gynacological malignancy
Familial gynacological malignancy
 
Breast cancer screening-2021 chan hio tong
Breast cancer screening-2021 chan hio tongBreast cancer screening-2021 chan hio tong
Breast cancer screening-2021 chan hio tong
 
CME: Gyaenecological Cancer screening in Family Medicine
CME: Gyaenecological Cancer screening in Family MedicineCME: Gyaenecological Cancer screening in Family Medicine
CME: Gyaenecological Cancer screening in Family Medicine
 
ENDOMETRIAL CANCER (1).pptx
ENDOMETRIAL CANCER (1).pptxENDOMETRIAL CANCER (1).pptx
ENDOMETRIAL CANCER (1).pptx
 

Minor abnormalities

  • 1. THE MANAGEMENT OF WOMEN WITH MINOR SMEAR ABNORMALITIES Dr Grainne Flannelly Colposcopy Course on line BSCCP
  • 2. Objectives • If you have a low grade smear what are the chances of having High grade CIN? • What are we trying to achieve in managing these women? • Management strategies – example of policies in evolution • How should these women be managed at Colposcopy? BSCCP on line course 2
  • 3. Aim of cervical screening –public health perspective Reduce the incidence and mortality of cervical cancer Detection and treatment of high grade precancerous lesions BSCCP on line course 3
  • 4. Aim of Cervical screening - woman's perspective To achieve a normal smear result!!! In the presence of any uncertainty to get further information BSCCP on line course 4
  • 5. Low grade cytological abnormalities in the NHSCSP In England in 2009, 239,907 women got a smear result with minor abnormality Most of these women do not have high grade CIN Category Number Inadequate 105,258 Negative 3,215,943 Borderline 153,471 Mild dyskaryosis 86,436 Moderate Dyskaryosis 21,839 Severe Dyskaryosis 24,186 ?Invasive cancer 929 Glandular 1,882 Total 3,609,944 (NHS statistics 2009/2010) BSCCP on line course 5
  • 6. In England in 2009, 51% of referrals to colposcopy were for low grade abnormalities Inadequate 2% BNA 19% Mild 32% Moderate 13% Severe 15% Glandular 0% Clinical urgent 1% Clinical non urgent 14% Other 4% Referrals to colposcopy BSCCP on line course 6
  • 7. Management Of Low Grade Smears; In Search Of Balance Risk of Cancer Risk of Harm BSCCP on line course 7
  • 8. Management options; the tools Repeat smears in the community Colposcopy and biopsy Triage with HPV tests? Traditional management • Cytological surveillance with colposcopy for repeated low grade. Recent guidelines • Immediate colposcopy is ideal for mild dyskaryosis” News: April 2011 • Introduction of HPV Triage for low grade abnormalities BSCCP on line course 8
  • 9. Core Issues Delay in diagnosis of high grade CIN Default Psychological impact Cost BSCCP on line course 9
  • 10. Advantages of early colposcopy strategy Recognition of covert CIN II-III Treatment/Eradication of abnormal cells Return to normal cytology Reassurance for woman Reassurance for doctor BSCCP on line course 10
  • 11. Low grade abnormalities and the natural history of HPV infection •Transmission by sex •Lifetime risk 80% - most within 18 months Exposure •Transient •Most resolve within 18 months Infection •Less than 20% persist •No antibodies detectable Persistence •Virus integrates into host DNA Malignant Transformation •Loss of tumour supressor gene E2 •Uncontrolled cells division CIN BSCCP on line course 11
  • 12. Natural history;ASCUS /Borderline smears are associated with an increased risk of high grade CIN • Risk of High grade CIN 10.1%, • Risk of invasive cancer 0.62%, • Relative risk of 15-30 for high grade CIN/Cancer ASCUS: • Relative risk of 3.5 for high grade CIN/Cancer ASCUS index smear followed by a normal smear Nygard,J.F., Acta Cytol, 2003. BSCCP on line course 12
  • 13. Natural history: Mild dyskaryosis - risk of subsequent high grade disease? Risk of Subsequent High Grade • Nassiel (n=555) 26% • Fletcher (n=666) 14% • Robertson (n=1347) 19% Risk of cancer on surveillance • 0.5% (Robertson) • 1% (Kirby) BSCCP on line course 13
  • 14. Woman's attitudes to mildly abnormal smear result 47% of women in immediate colposcopy group thought they had cancer 33% of women in the surveillance group thought they had cancer Following an educational interview • Most women with LSil chose Colposcopy Following an educational interview • Most women with ASCUS chose virus testing (ALTS Study) BSCCP on line course 14
  • 15. What about including patient choice? 476 women randomised to either surveillance or choice between immediate colposcopy or surveillance Both groups of women showed high levels of anxiety initially. No difference between the two groups Fewer women defaulted in the choice arm (Kitchener, 2004) BSCCP on line course 15
  • 16. Cytological Surveillance is less efficient than immediate colposcopy - Tombola Detection of high grade disease • Immediate colposcopy Cumulative detection - 79/1000 person years • Cytological surveillance Cumulative detection 58/1000 person years. Anxiety • Both strategies were associated with anxiety • No difference between two arms (BMJ, 2009) BSCCP on line course 16
  • 17. Time for a radical change in approach? BSCCP on line course 17
  • 18. HPVAs Triage For Women WithASCUS;AMeta- analysis • Sensitivity 94.8% • Specificity 67.3% HPV testing (HC 2) • Sensitivity 81.8% • Specificity 57.6% Cytology The addition of HPV testing to cytology increased sensitivity Arbyn et al, J Natl Cancer Inst. 2004 Feb 18;96(4):280-93. BSCCP on line course 18
  • 19. HPV testing increases the numbers referred for colposcopy 3488 women with ASCUS/LSIL HPV Testing • 95.9% sensitivity for high grade CIN Would have resulted in 56% of women being referred for colposcopy (ALTS study, Solomons, 2001) Size of impact depends on preexisting policy regarding women with mild dyskaryosis BSCCP on line course 19
  • 20. NHS Triage Pilot in Three laboratories BMJ 2006 • Repeat smears reduced significantly (70-87%) • Referrals to colposcopy doubled BSCCP on line course 20
  • 21. Risks of Triage; Psychosocial HPV triage has the potential to increase anxiety in women • It could result in an explicit diagnosis of a sexually transmitted infection • Increased rate of Solutions • High quality information • Adequate colposcopy capacity to maintain low waiting times BSCCP on line course 21
  • 22. Psychological Impact; Australia • HPV positive result was associated with initial distress as was repeat pap testing • Levels of distress decreased with time Mc Caffrey K, BMJ 2010 BSCCP on line course 22
  • 23. Women with low grade abnormalities; management at colposcopy- Tombola Comparison of immediate LLETZ versus biopsy and deferred treatment • 60% of LLETZ showed no CIN • No difference in cumulative detection of CIN 2/3 Targeted punch biopsies with • Subsequent treatment for CIN2/3 • Cytological surveillance for grade I or less Immediate treatment with LLETZ should be avoided BMJ 2009;339:b2548 BSCCP on line course 23
  • 24. Management at Colposcopy NewAlgorithm - NHSCSP Triage Borderline/Mild dyskaryosis HPV + Colposcopy+- Biopsy Abnormal CIN2/3 Treatment CIN1 Repeat smear in 12 months Normal HPV - Routine Recall BSCCP on line course 24
  • 25. Evidence for early discharge if colposcopy normal 965 women in NHS Pilot sites with low grade cytology and HPV + with negative colposcopy with or without biopsy at recruitment • 94.6% of cases of CIN2/3 were detected at the first visit to colposcopy • 42 cases of CIN 2/3 were identified within 3 years Kelly et al, BJOG May 2011) Good quality colposcopy will be essential if these results are to be reproducible in routine practice ! BSCCP on line course 25
  • 26. Conclusions The road ahead Key questions • Role of colposcopy – especially negative colposcopy • Compliance • New tests – biomarkers? BSCCP on line course 26